Clinical Trial: A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07204275) titled 'A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)' on Sept. 24.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of povetacicept in participants with primary membranous nephropathy (pMN).

Study Start Date: Oct. 06

Study Type: INTERVENTIONAL

Condition: Primary Membranous Nephropathy

Intervention: DRUG: Povetacicept

Solution for Subcutaneous Injection.

DRUG: Tacrolimus

Tablets for Oral Administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vertex Pharmaceuticals Incorporated

Published by HT D...